Amelioration of non-alcoholic steatohepatitis and glucose intolerance in ob/ob mice by glucocerebroside is associated with an altered NKT lymphocyte distribution.

被引：0
|
作者：
Margalit, M [1 ]
Shalev, Z [1 ]
Pappo, O [1 ]
Sklair-Levy, M [1 ]
Engelhardt, D [1 ]
Rabbani, E [1 ]
Ilan, Y [1 ]
机构：
[1] Hadasah Hebrew Univ Med Ctr, Jerusalem, Israel
来源：
HEPATOLOGY | 2004年 / 40卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：431A / 431A
页数：1
相关论文
共 50 条
  • [21] Moderate alcohol consumption diminishes the development of non-alcoholic fatty liver disease (NAFLD) in ob/ob mice
    Kanuri, Giridhar
    Landmann, Marianne
    Priebs, Josephine
    Spruss, Astrid
    Loescher, Marina
    Ziegenhardt, Doreen
    Roehi, Carolin
    Degen, Christian
    Bergheim, Ina
    EUROPEAN JOURNAL OF NUTRITION, 2016, 55 (03) : 1153 - 1164
  • [22] Effect of moderate alcohol consumption on the development of non-alcoholic fatty liver disease (NAFLD) in ob/ob mice
    Kanuri, Giridhar
    Loescher, Marina
    Stahl, Carolin
    Bischoff, Stephan C.
    Bergheim, Ina
    HEPATOLOGY, 2012, 56 : 874A - 875A
  • [23] Hepatic Macrosteatosis Is Partially Converted to Microsteatosis by Melatonin Supplementation in ob/ob Mice Non-Alcoholic Fatty Liver Disease
    Stacchiotti, Alessandra
    Favero, Gaia
    Lavazza, Antonio
    Golic, Igor
    Aleksic, Marija
    Korac, Aleksandra
    Rodella, Luigi Fabrizio
    Rezzani, Rita
    PLOS ONE, 2016, 11 (01):
  • [24] A Novel Gubra Amylin Nash (GAN) Diet-Induced Ob/Ob Mouse Model of Biopsy-Confirmed Non-Alcoholic Steatohepatitis
    Hansen, Henrik B.
    Boland, Michelle L.
    Oro, Denise
    Tolbol, Kirstine Sloth
    Illemann, Martin
    Veidal, Sanne
    Feigh, Michael
    Jelsing, Jacob
    Vrang, Niels
    Trevaskis, James
    HEPATOLOGY, 2018, 68 : 1034A - 1035A
  • [25] REGULATION OF BILE SALT TRANSPORTERS IN NON-ALCOHOLIC FATTY LIVER DISEASE IN OB/OB-MICE AND HUMAN FATTY LIVERS
    Martin, I. V.
    Minkenberg, A.
    Canbay, A.
    Muellhaupt, B.
    Geier, A.
    JOURNAL OF HEPATOLOGY, 2009, 50 : S263 - S263
  • [26] Preventive effect of Silibinin in combination with Pu-erh tea extract on non-alcoholic fatty liver disease in ob/ob mice
    Hu, Wen-Yi
    Ma, Xiao-Hui
    Zhou, Wang-Yi
    Li, Xin-Xin
    Sun, Ting-Ting
    Sun, He
    FOOD & FUNCTION, 2017, 8 (03) : 1105 - 1115
  • [27] Roflumilast ameliorates GAN diet-induced non-alcoholic fatty liver disease by reducing hepatic steatosis and fibrosis in ob/ob mice
    Wang, Bin
    Zhu, Xiaochan
    Yu, Siting
    Xue, Huan
    Deng, Lijiao
    Zhang, Yushan
    Zhang, Yi
    Liu, Yunfeng
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2024, 722
  • [28] Pilot study of liraglutide effects in non-alcoholic steatohepatitis and non-alcoholic fatty liver disease with glucose intolerance in Japanese patients (LEAN-J)
    Eguchi, Yuichiro
    Kitajima, Yoichiro
    Hyogo, Hideyuki
    Takahashi, Hirokazu
    Kojima, Motoyasu
    Ono, Masafumi
    Araki, Norimasa
    Tanaka, Kenichi
    Yamaguchi, Miyuki
    Matsuda, Yayoi
    Ide, Yasushi
    Otsuka, Taiga
    Ozaki, Iwata
    Ono, Naofumi
    Eguchi, Takahisa
    Anzai, Keizo
    HEPATOLOGY RESEARCH, 2015, 45 (03) : 269 - 278
  • [29] Salvianolic acid B ameliorates non-alcoholic fatty liver disease by inhibiting hepatic lipid accumulation and NLRP3 inflammasome in ob/ob mice
    Meng, Ling-Cui
    Zheng, Jia-Yi
    Qiu, Yu-Hui
    Zheng, Li
    Zheng, Jue-Yan
    Liu, Yu-Qing
    Miao, Xiao-Lu
    Lu, Xin-Yi
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2022, 111
  • [30] Fortifying Butterfat with Soybean Oil Attenuates the Onset of Diet-Induced Non-Alcoholic Steatohepatitis and Glucose Intolerance
    Sanchez, Victor
    Brandt, Annette
    Jin, Cheng Jun
    Rajcic, Dragana
    Engstler, Anna Janina
    Jung, Finn
    Nier, Anika
    Baumann, Anja
    Bergheim, Ina
    NUTRIENTS, 2021, 13 (03) : 1 - 18
12345